We then wanted to assess whether TGF‐β1/Smad4 signalling was required for the phenotypic changes to PCa cells upon Glo1 knock‐down by the TGFβ1, inhibitor SB431542. The gene discussed is SMAD4; the disease is posterior cortical atrophy.